Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v9-FR
Language French French
Date Updated 2023-01-19 2023-01-06
Drug Identification Number 02224755 02224755
Brand name LASIX SPECIAL LASIX SPECIAL
Common or Proper name LASIX SPECIAL LASIX SPECIAL
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients FUROSEMIDE FUROSEMIDE
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size Bottle of 20 tablets Bottle of 20 tablets
ATC code C03CA C03CA
ATC description HIGH-CEILING DIURETICS HIGH-CEILING DIURETICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-10-21 2022-10-21
Actual start date 2022-10-25 2022-10-25
Estimated end date 2023-01-31 2023-01-31
Actual end date 2023-01-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments